Upcoming Courses
Essential Psychopharmacology, 2016
Carl Salzman, MD
This course will provide a simplified and clinically relevant updated review of neurobiology and brain function. Areas of emphasis will be the psychopharmacologic of treatment will include treatment of schizophrenia, bipolar disorder, depression, anxiety, sleep disorders and borderline personality. The effectiveness of atypical and conventional anti-psychotic drugs as well as long acting new medications will be reviewed. Augmenting agents for schizophrenia will also be reviewed. The course will address strategies for bipolar patients who are noncompliant or treatment resistant; approaches to the acutely psychotic, recovering psychotic patient, and the concept of early intervention. The role of inflammation and its relationship to mood disorders will be emphasized. Psychiatric medications for the elderly will be reviewed, including dosage adjustments for age, drug interactions, and sensitivity to side effects. The role of psychopharmacology in the treatment of obsessive symptoms, panic symptoms, and traumatic syndromes will be emphasized. New information regarding the role of medications for substance abuse will presented. In addition, the therapeutic role of stimulants for adult individuals with a variety of psychiatric diagnoses will be reviewed. The course will emphasize the establishment and importance of therapeutic alliance when prescribing all psychotropic medications, the interplay between pharmacologic and non-pharmacologic treatments, benefits and hazards of prescriber/ non-prescriber co-treatment relationships. Educational presentation will be in seminar format and include lectures, participant discussion and Q & A.
- Analyze the latest research in neurobiology and brain function;
- Implement treatment strategies for depressive and bipolar patients, including bipolar patients who are noncompliant or treatment resistant;
- Incorporate evidence-based approaches to treating acutely psychotic and recovering psychotic patients;
- Determine when to implement medical switch versus augmentation strategies for treatment-resistant depression;
- Describe the role of inflammation in mood disorders;
- Make dosage adjustments in the elderly for age, drug interactions, and sensitivity to side effects;
- Describe the role of psychopharmacology in the treatment of generalized anxiety disorder, obsessive symptoms, panic symptoms, and traumatic syndromes;
- Describe the interplay between pharmacologic and non-pharmacologic treatments;
- Identify the mechanisms and treatment for alcohol and substance abuse disorders;
- Determine the role of antidepressants in the life cycle of women;
- Describe the use of stimulants in adult individuals with psychiatric disorders.
Additional Information
Monday, February 29, 2016
| 8:00 AM – 9:00 AM |
Registration
Coffee and Tea will be available during registration
|
 |
| 9:00 AM – 10:00 AM |
An Updated and Clinically Relevant Review of Neurobiology
An updated and clinically relevant review of neurobiology as it applies to the etiology and pathology of psychiatric illness, and psychotropic drug treatment effects
Speaker: |
|
| 10:00 AM – 10:15 AM |
Coffee Break
Continental Breakfast will be served
|
|
| 10:15 AM – 12:15 PM |
The Neurobiology of “Attachment”
Q&A.
Speaker: |
|
Tuesday, March 1, 2016
| 9:00 AM – 10:00 AM |
Biology and Treatment of Psychotic Disorders
Biology and treatment of psychotic disorders including schizophrenia, bipolar illness, psychotic depression, and psychosis associated with neurologic conditions; current standards of practice; new uses for atypical antipsychotic drugs
Speaker: |
|
| 10:00 AM – 10:15 AM |
Coffee Break
Continental Breakfast will be served
|
|
| 10:15 AM – 12:15 PM |
CATIE Study and Other Recent Clinical Trials of New Antipsychotic Drugs
Special emphasis on evidence-based treatments of bipolar depression; CATIE study and other recent clinical trials of new antipsychotic drugs. Q&A.
Speaker: |
|
Wednesday, March 2, 2016
| 9:00 AM – 10:00 AM |
Neurobiological Mechanisms of Depression and its Psychopharmacological Treatments
Neurobiological mechanisms of depression and its psychopharmacological treatments, including major depression, bipolar depression, and dysthymia; depression associated with medical illnesses, especially cardiovascular and endocrine disorders;
Speaker: |
|
| 10:00 AM – 10:15 AM |
Coffee Break
Continental Breakfast will be served
|
|
| 10:15 AM – 12:15 PM |
Treatments of Medically Related Depressions
Treatments of medically related depressions; STAR*D study and other evidenced based clinical trials. Q&A.
Speaker: |
|
Thursday, March 3, 2016
| 9:00 AM – 10:00 AM |
Anxiety and Anxiety-Spectrum Disorders
Anxiety and anxiety-spectrum disorders; neurobiological mechanisms of anxiety, and the appropriate role of treatments with benzodiazepines, antidepressants, and new approaches
Speaker: |
|
| 10:00 AM – 10:15 AM |
Coffee Break
Continental Breakfast will be served
|
|
| 10:15 AM – 12:15 PM |
Role of Anxiety and Stress Mechanisms as an Etiologic Factor in Psychiatric Illness
Role of anxiety and stress mechanisms as an etiologic factor in psychiatric illness with suggestions for treatment and prevention. Q&A
Speaker: |
|
Friday, March 4, 2016
| 9:00 AM – 10:00 AM |
Psychotropic Drug Treatment of Psychiatric Disorders Common in Late Life
Psychotropic drug treatment of psychiatric disorders common in late life; treatment of addictive disorders, pregnancy and lactation and eating disorders;
Speaker: |
|
| 10:00 AM – 10:15 AM |
Coffee Break
Continental Breakfast will be served
|
|
| 10:15 AM – 12:15 PM |
Presentation of Interesting/Difficult Cases from Attendee’s Practice for Discussion and Review
Q&A
Speaker: |
Beth Israel Deaconess Department of Psychiatry Foundation, Inc./Contact Hours: 15
Accreditation:
PHYSICIANS: The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Harvard Medical School designates this live activity for a maximum of 15 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Royal College of Physicians and Surgeons of Canada recognizes conferences and workshops held outside of Canada that are developed by a university, academy, hospital, specialty society or college as accredited group learning activities.
AMA PRA Category 1 Credits™ claimed by physicians attending live events certified and organized in the United States for AMA PRA Category 1 Credits™ can be claimed through the agreement on mutual recognition of credits between UEMS and AMA, considered as being equal to the European Continuous Medical Education Credits (ECMEC©) granted by the UEMS. One AMA PRA Category 1 Credit™ is equivalent to one (1) hour of European EACCME Credit (ECMEC©), therefore up to 15 ECMEC© Credits are available. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Psychologists:The Continuing Education Program at Beth Israel Deaconess Medical School, a major teaching hospital of Harvard Medical School, is approved by the American Psychological Association to offer Continuing education for psychologists. The Continuing Education Program at Beth Israel Deaconess Medical School, a major teaching hospital of Harvard Medical School, maintains responsibility for this program.
Counselors: The Continuing Education Program at Beth Israel Deaconess Medical Center, a major teaching hospital of Harvard Medical School, is an NBCC-Approved Continuing Education Provider (ACEPTM) and may offer NBCC-approved clock hours for events that meet NBCC requirements. The ACEPTM solely is responsible for all aspects of the program.” The winter seminar programs meet the criteria for 15 clock hours.
Social Workers: Application for social work continuing education credits has been submitted.
Nurses: This activity has been submitted to the American Nurses Association Massachusetts for approval to award contact hours. The American Nurses Association Massachusetts is accredited as an approver of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Please call Stacy Ruiz at 617-754-1265 or e-mail sjruiz@bidmc.harvard.edu for more information about your credit hours.